Filing Details
- Accession Number:
- 0001387131-22-009717
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-12 17:45:16
- Reporting Period:
- 2022-09-08
- Accepted Time:
- 2022-09-12 17:45:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1570562 | Evolus Inc. | EOLS | Pharmaceutical Preparations (2834) | 461385614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1848514 | Medytox Inc. | 78, Gangni 1-Gil, Ochang-Eup, Cheongwon-Gu Cheongju-Si M5 28126 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.00001 Par Value Per Share | Disposition | 2022-09-08 | 15,300 | $10.39 | 7,422,352 | No | 4 | S | Direct | |
| Common Stock, $0.00001 Par Value Per Share | Disposition | 2022-09-09 | 20,700 | $10.53 | 7,401,652 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.34 to $10.50, inclusive. The reporting person undertakes to provide to Evolus, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.45 to $10.70, inclusive.
Billionaire Hedge Funds
